About BRO1 domain-containing protein BROX
BRO1 domain-containing protein BROX (BROX) is a protein
from Homo sapiens identified by UniProt accession
Q5VW32, 411 residues long.
MolForge cross-references it against 0 known binders and
30 disease associations.
Target properties
| Protein name | BRO1 domain-containing protein BROX |
| UniProt accession | Q5VW32 |
| Gene | BROX |
| Organism | Homo sapiens |
| Length | 411 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (30)
Diseases linked to this target (Open Targets).
- appendicular lean mass · score 0.26
- coronary artery bypass · score 0.15
- coronary artery disease · score 0.14
- angina pectoris · score 0.09
- cardiovascular disease · score 0.07
- myocardial infarction · score 0.06
- metabolite measurement · score 0.05
- Vasodilators used in cardiac diseases use measurement · score 0.04
- HMG CoA reductase inhibitor use measurement · score 0.04
- aspirin use measurement · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5VW32-F1 | alphafold | PREDICTED | 92.04 | — |
Amino-acid sequence (411 residues)
MTHWFHRNPL KATAPVSFNY YGVVTGPSAS KICNDLRSSR ARLLELFTDL SCNPEMMKNA ADSYFSLLQG FINSLDESTQ ESKLRYIQNF KWTDTLQGQV PSAQQDAVFE LISMGFNVAL WYTKYASRLA GKENITEDEA KEVHRSLKIA AGIFKHLKES HLPKLITPAE KGRDLESRLI EAYVIQCQAE AQEVTIARAI ELKHAPGLIA ALAYETANFY QKADHTLSSL EPAYSAKWRK YLHLKMCFYT AYAYCYHGET LLASDKCGEA IRSLQEAEKL YAKAEALCKE YGETKGPGPT VKPSGHLFFR KLGNLVKNTL EKCQRENGFI YFQKIPTEAP QLELKANYGL VEPIPFEFPP TSVQWTPETL AAFDLTKRPK DDSTKPKPEE EVKPVKEPDI KPQKDTGCYI S
Explore BRO1 domain-containing protein BROX with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets